Bruker Corporation (BRKR)

Debt-to-equity ratio

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Long-term debt	US$ in thousands	2,061,800	2,264,500	2,132,000	1,357,300	1,160,300	1,098,600	1,122,500	1,109,000	1,200,500	1,136,800	1,171,000	1,205,400	1,221,800	717,500	721,100	715,800	842,300	828,200	924,200	914,800
Total stockholders’ equity	US$ in thousands	1,781,200	1,807,000	1,789,200	1,415,300	1,377,200	1,208,800	1,231,200	1,180,300	1,113,800	937,000	970,500	1,017,000	1,070,500	1,075,600	1,002,000	967,700	961,200	952,100	897,400	915,600
Debt-to-equity ratio		1.16	1.25	1.19	0.96	0.84	0.91	0.91	0.94	1.08	1.21	1.21	1.19	1.14	0.67	0.72	0.74	0.88	0.87	1.03	1.00

December 31, 2024 calculation

Debt-to-equity ratio = Long-term debt ÷ Total stockholders’ equity
= $2,061,800K ÷ $1,781,200K
= 1.16

Based on the data provided, Bruker Corporation's debt-to-equity ratio has shown some fluctuations over the reporting periods.

The debt-to-equity ratio was 1.00 as of March 31, 2020, indicating that the company had an equal amount of debt and equity. This ratio increased to 1.03 by June 30, 2020, and then gradually decreased to 0.67 by September 30, 2021. This declining trend suggests that the company was relying less on debt financing and more on equity during this period.

However, there was a significant spike in the debt-to-equity ratio to 1.14 by December 31, 2021, and further to 1.21 by June 30, 2022. This increase indicates that Bruker Corporation might have taken on more debt compared to its equity during these periods.

Subsequently, the ratio decreased to 0.84 by December 31, 2023, before fluctuating between 0.91 and 1.25 from March 31, 2024, to September 30, 2024. These fluctuations suggest some variability in the company's capital structure and its use of debt for financing operations.

Overall, the debt-to-equity ratio provides insights into how Bruker Corporation is leveraging debt and equity to fund its operations and growth. It is essential to monitor this ratio over time to assess the company's financial health and risk profile.